Literature DB >> 11016941

The channel-forming protein proaerolysin remains a dimer at low concentrations in solution.

R Barry1, S Moore, A Alonso, J Ausió, J T Buckley.   

Abstract

Proaerolysin, the proform of the channel-forming protein aerolysin, is secreted as a dimer by Aeromonas sp. The protein also exists as a dimer in the crystal, as well as in solution, at least at concentrations in the region of 500 microg/ml. Recently it has been argued that proaerolysin becomes monomeric at concentrations below 100 microg/ml and that only the monomeric form of the protoxin can bind to cell surface receptors (Fivaz, M., Velluz, M.-C., and van der Goot, F. G. (1999) J. Biol. Chem. 274, 37705-37708). Here we show, using non-denaturing polyacrylamide electrophoresis, chemical cross-linking, and analytical ultracentrifugation, that proaerolysin remains dimeric at the lowest concentrations of the protein that we measured (less than 5 microg/ml) and that the dimeric protoxin is quite capable of receptor binding.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11016941     DOI: 10.1074/jbc.M008097200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  3 in total

1.  The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins.

Authors:  Madhuri Wadehra; Lee Goodglick; Jonathan Braun
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

2.  Intramolecular dimerization is required for the chlamydia-secreted protease CPAF to degrade host transcriptional factors.

Authors:  Feng Dong; Jyotika Sharma; Yanming Xiao; Youmin Zhong; Guangming Zhong
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

3.  Site-specific chemoenzymatic labeling of aerolysin enables the identification of new aerolysin receptors.

Authors:  Irene Wuethrich; Janneke G C Peeters; Annet E M Blom; Christopher S Theile; Zeyang Li; Eric Spooner; Hidde L Ploegh; Carla P Guimaraes
Journal:  PLoS One       Date:  2014-10-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.